Cover Image
市場調查報告書

益生菌的全球市場:市場機會及未來預測

World Probiotics Market - Opportunities and Forecasts, 2014-2022

出版商 Allied Market Research 商品編碼 370257
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
益生菌的全球市場:市場機會及未來預測 World Probiotics Market - Opportunities and Forecasts, 2014-2022
出版日期: 2016年08月01日 內容資訊: 英文 125 Pages
簡介

全球各地消費者的健康意識高漲,機能性食品的消費量持續增加,促進益生菌產品市場成長。另一方面,消費者未清楚知道益生菌的優點,及產品規格、管理體制的不足,也有妨礙市場成長的可能性。

本報告提供全球益生菌產品的市場相關分析,產品概要和市場結構、最新趨勢,市場向心力,相關產業的關聯性,主要的推動及阻礙市場要素,今後的市場機會,市場規模的成果值、預測值 (過去2年、今後7年份),各成分、各功能、各應用領域、各終端用戶及各地區詳細趨勢,主要企業簡介等的相關調查。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 分析的要點
    • 最大的影響要素
    • 主要的成功策略
    • 最大的投資資金來源
  • 波特的五力分析
  • 價值鏈分析
  • 市場佔有率分析
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 市場機會

第4章 全球益生菌市場:各成分

  • 概要
    • 市場規模與其預測
  • 細菌
    • 市場主要趨勢
    • 主要的成長要素與市場機會
    • 市場規模與其預測
  • 酵母

第5章 全球益生菌市場:各功能

  • 概要
    • 市場規模與其預測
  • 通常品
    • 市場主要趨勢
    • 主要的成長要素與市場機會
    • 市場規模與其預測
  • 預防醫療用產品
  • 疾病治療用產品

第6章 全球益生菌市場:各應用領域

  • 概要
    • 市場規模與其預測
  • 食品、飲料
    • 市場主要趨勢
    • 主要的成長要素與市場機會
    • 市場規模與其預測
  • 補充品 (營養補充品)
  • 飼料

第7章 全球益生菌市場:各最終用途

  • 概要
    • 市場規模與其預測
  • 人類用益生菌
    • 市場主要趨勢
    • 主要的成長要素與市場機會
    • 市場規模與其預測
  • 動物用益生菌

第8章 全球益生菌市場:各地區

  • 概要
  • 北美 (美國、墨西哥、加拿大)
    • 市場主要趨勢
    • 主要的成長要素與市場機會
    • 市場規模與其預測 (各國層級)
  • 歐洲 (英國、德國、法國、義大利等)
  • 亞太地區 (中國、日本、印度等)
  • 南美、中東、非洲 (LATEM)

第9章 企業簡介

  • Yakult Honsha Co Ltd
    • 企業概要
    • 企業的最新趨勢
    • 業績
    • 事業領域
    • 策略發展情形
  • BioGaia AB
  • Danone
  • E. I. du Pont de Nemours and Company
  • Probi AB
  • Ganeden, Inc.
  • Protexin
  • Nestle S.A.
  • Chr. Hansen Holding A/S
  • Lifeway Foods, Inc.

圖表一覽

目錄
Product Code: FO 16282

Title: World Probiotics Market by Ingredient (Bacteria, Yeast), Application (Food & Beverages, Dietary Supplements, Animal Feed), Function (Regular, Preventative Healthcare, Therapeutic) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022.

Cover Image Probiotics are microorganisms, such as bacteria and yeast, that are very useful to sustain the balance of intestinal microbial in human and animal body. Probiotic ingredients stimulate natural digestive juices and enzymes in the body to ensure proper functioning of the digestive system. In addition, probiotics protect healthy organisms from harmful microorganisms. Nowadays, probiotic products find applications to diagnose mental illness and treat digestive problems & neurological disorders. Moreover, they strengthen the human immune system, protect proteins & lipids from oxidative destruction, and reduce body pathogens. Probiotic ingredients can be administered through food or in the form of supplements. In addition, these ingredients are sold in the form of capsules, tablets, powders, and gel.

The major factor that boosts the market growth is increase in consumer preference for natural products. Rise in concerns of consumers on preventive healthcare and effectiveness of probiotic bacteria on health drive the market growth. The demand of probiotics has increased due to upsurge in consumption of functional foods, which have potentially positive effects on health apart from providing basic nutrition. Besides, factors such as ban on the usage of antibiotics in animal feed in several countries, increase in product innovations in the form of chocolates, biscuits & others, increased demand of probiotic based medicines for chronic diseases such as diarrhea & bowel diseases drives the market growth. In addition, increase in disposable income and improved standards of living in developing economies supplement the market growth.

The factors that restrict the market growth are lack of standardization regarding microorganism concentration in probiotic products, high prices of ingredients and lack of awareness regarding benefits of probiotics among consumers. Proactive government support such as approval from Food & Drug Administration for probiotic dietary supplements & Foods for Specific Health Uses are expected to offer lucrative opportunities for market growth. Also, several publications on probiotics, functional food fact sheets, and conferences by International Food Information Council (IFIC) have increased awareness about probiotic products, which are expected to drive the market.

The world probiotics market is segmented based on ingredient, application, function, end use, and geography. Based on ingredient, the market is segmented into bacteria and yeast. Probiotic foods such as Yogurt and Kefirs are induced with probiotic bacteria either in powdered or liquid form. Yeast probiotics are used for therapeutic purposes also. Bacterial strains are available in powdered, liquid, and in gel forms whereas yeast strains are available only in powdered form. Bacteria segment accounted for the maximum revenue share in the year 2014 and is anticipated to consolidate its position during the forecast period, owing to its health benefits such as improve lactose digestion, prevention of urogenital infections, and treatment of allergies.

Based on application, the market is segmented into food & beverages, dietary supplements, and animal feed. Food & beverages is the most preferred mode of consumption of probiotics and is expected to maintain its dominance during the forecast period. Dietary supplements segment is expected to be the fastest growing segment during the forecast period, due to rise in demand for botanical and natural health supplements, which will help maintain good gut health and strong immune system.

Based on function, the market is divided into regular, preventive healthcare, and therapeutic. Among these, preventive healthcare function is expected to grow with a highest growth rate due to rise in application in pharmaceutical industry to regulate the digestion and normalize the intestinal tract. By end use, the probiotics market is segmented into animal probiotics and human probiotics. Human probiotics dominated the overall probiotics market in 2014 and this segment is anticipated to generate highest revenue throughout the forecast period.

The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA along with their prominent respective countries. Asia-Pacific would continue to be the highest revenue-generating region during the forecast period. Factors such as rapid growth in the food & beverage industry in developing countries, such as India and China, and rise in awareness of benefits of probiotic food products drive the market. The key players operating in this market include BioGaia AB, Danone, Chr. Hansen Holding A/S, Yakult Honsha Co., Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., E. I. du Pont de Nemours and Company, and Protexin.

KEY BENEFITS

  • This report provides an in-depth analysis of the world probiotics market to elucidate the potential investment pockets.
  • The current trends and future scenarios are outlined to determine the overall market potential and single out profitable trends to gain a stronger foothold in the market.
  • This report provides information regarding key drivers, restraints, and opportunities along with their detailed impact analysis.
  • Quantitative analysis of the current market trends and estimations for the period of 2014-2022 are provided to indicate its financial competency.
  • Porters Five Forces Model of the industry illustrate the potency of buyers and suppliers.
  • Value chain analysis provides a clear understanding on the roles of stakeholders in the industry.

Market Segmentation

By Ingredient

  • Bacteria
  • Yeast

By Function

  • Regular
  • Preventive Healthcare
  • Therapeutic

By Application

  • Food & Beverage
  • Dietary Supplements
  • Animal Feed

By End Use

  • Human Probiotics
  • Animal Probiotics

By Geography

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe (The Netherlands, Spain, Turkey and others)
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific (Singapore, Australia, Thailand, and others)
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top winning strategies
    • 3.2.3. Top investment pockets
  • 3.3. Porter's Five forces analysis
    • 3.3.1. Growing number of market players results in moderate bargaining power of buyers
    • 3.3.2. Limited number of quality raw material suppliers increases the bargaining power of suppliers
    • 3.3.3. Well established industry giants and huge investment limits the emergence of new entrants
    • 3.3.4. Lack of viable substitute leads to low threat of substitutes
    • 3.3.5. Well-established brands and growing market lead to moderate rivalry among competitors
  • 3.4. Value chain analysis
  • 3.5. Market share analysis, 2015
  • 3.6. Market dynamics
    • 3.6.1. Drivers
      • 3.6.1.1. Growing health concerns
      • 3.6.1.2. Rising consumption of functional foods
      • 3.6.1.3. Increasing investment on research & development
    • 3.6.2. Restraints
      • 3.6.2.1. Low awareness level among consumers about effectiveness of probiotic products
      • 3.6.2.2. Government regulations
    • 3.6.3. Opportunities
      • 3.6.3.1. Rising demand of probiotic products in developing nations
      • 3.6.3.2. Creating awareness about the benefits of probiotics

CHAPTER 4: WORLD PROBIOTICS MARKET, BY INGREDIENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Bacteria
    • 4.2.1. Key market trends
    • 4.2.2. Key growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. Yeast
    • 4.3.1. Key market trends
    • 4.3.2. Key growth factors and opportunities
    • 4.3.3. Market size and forecast

CHAPTER 5: WORLD PROBIOTICS MARKET, BY FUNCTION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Regular
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
  • 5.3. Preventative healthcare
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast
  • 5.4. Therapeutic
    • 5.4.1. Key market trends
    • 5.4.2. Key growth factors and opportunities
    • 5.4.3. Market size and forecast

CHAPTER 6: WORLD PROBIOTICS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Food & Beverage
    • 6.2.1. Key market trends
    • 6.2.2. Key growth factors and opportunities
    • 6.2.3. Market size and forecast
  • 6.3. Dietary supplements
    • 6.3.1. Key market trends
    • 6.3.2. Key growth factors and opportunities
    • 6.3.3. Market size and forecast
  • 6.4. Animal feed
    • 6.4.1. Key market trends
    • 6.4.2. Key growth factors and opportunities
    • 6.4.3. Market size and forecast

CHAPTER 7: WORLD PROBIOTICS MARKET, BY END USE

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Human probiotics
    • 7.2.1. Key market trends
    • 7.2.2. Key growth factors and opportunities
    • 7.2.3. Market size and forecast
  • 7.3. Animal probiotics
    • 7.3.1. Key market trends
    • 7.3.2. Key growth factors and opportunities
    • 7.3.3. Market size and forecast

CHAPTER 8: WORLD PROBIOTICS MARKET, BY GEOGRAPHY

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. Key market trends
    • 8.2.2. Key growth factors and opportunities
    • 8.2.3. Market size and forecast
      • 8.2.3.1. U.S.
      • 8.2.3.2. Mexico
      • 8.2.3.3. Canada
  • 8.3. Europe
    • 8.3.1. Key market trends
    • 8.3.2. Key growth factors and opportunities
    • 8.3.3. Market size and forecast
      • 8.3.3.1. UK
      • 8.3.3.2. Germany
      • 8.3.3.3. France
      • 8.3.3.4. Italy
      • 8.3.3.5. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends
    • 8.4.2. Key growth factors and opportunities
    • 8.4.3. Market size and forecast
      • 8.4.3.1. China
      • 8.4.3.2. Japan
      • 8.4.3.3. India
      • 8.4.3.4. Rest of Asia-Pacific
  • 8.5. LAMEA
    • 8.5.1. Key market trends
    • 8.5.2. Key growth factors and opportunities
    • 8.5.3. Market size and forecast
      • 8.5.3.1. Latin America
      • 8.5.3.2. Middle East
      • 8.5.3.3. Africa

CHAPTER 9: COMPANY PROFILE

  • 9.1. Yakult Honsha Co., Ltd.
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Business performance
    • 9.1.4. Operating business segments
    • 9.1.5. Strategic moves & developments
  • 9.2. BioGaia AB
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Business performance
    • 9.2.4. Operating business segments
    • 9.2.5. Strategic moves & developments
  • 9.3. Danone
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Business performance
    • 9.3.4. Operating business segments
    • 9.3.5. Strategic moves & developments
  • 9.4. E. I. du Pont de Nemours and Company
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Business performance
    • 9.4.5. Strategic moves & developments
  • 9.5. Probi AB
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Business performance
    • 9.5.4. Operating business segments
    • 9.5.5. Strategic moves & developments
  • 9.6. Ganeden, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Strategic moves and developments
  • 9.7. Protexin
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Operating business segments
    • 9.7.4. Strategic moves and developments
  • 9.8. Nestle S.A.
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Business performance
    • 9.8.4. Operating business segments
    • 9.8.5. Strategic moves and developments
  • 9.9. Chr. Hansen Holding A/S
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Business performance
    • 9.9.4. Operating business segments
    • 9.9.5. Strategic moves and developments
  • 9.10. Lifeway Foods, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Company snapshot
    • 9.10.3. Business performance
    • 9.10.4. Operating business segments
    • 9.10.5. Strategic moves and developments

List of Tables

  • TABLE 1: WORLD PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 2: WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014-2022 ($MILLION)
  • TABLE 3: WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 4: WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 5: WORLD PROBIOTICS MARKET BY FUNCTION, 2014-2022 ($MILLION)
  • TABLE 6: WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 7: WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 8: WORLD THERAPEUTIC PROBIOTICS BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 9: WORLD PROBIOTICS MARKET BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 10: WORLD FOOD & BEVERAGES PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 11: WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 12: WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 13: WORLD PROBIOTICS MARKET BY END USE, 2014-2022 ($MILLION)
  • TABLE 14: WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 15: WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
  • TABLE 16: NORTH AMERICA PROBIOTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 17: NORTH AMERICA PROBIOTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 18: EUROPE PROBIOTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 19: EUROPE PROBIOTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 20: ASIA-PACIFIC PROBIOTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 21: ASIA-PACIFIC PROBIOTICS MARKET, BY COUNTRY, 2015-2022 ($MILLION)
  • TABLE 22: LAMEA PROBIOTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
  • TABLE 23: LAMEA PROBIOTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
  • TABLE 24: YAKULT HONSHA CO., LTD. - COMPANY SNAPSHOT
  • TABLE 25: YAKULT HONSHA CO., LTD.- OPERATING SEGMENTS
  • TABLE 26: BIOGAIA AB - COMPANY SNAPSHOT
  • TABLE 27: BIOGAIA AB- OPERATING SEGMENTS
  • TABLE 28: DANONE - COMPANY SNAPSHOT
  • TABLE 29: DANONE - OPERATING SEGMENTS
  • TABLE 30: E. I. DU PONT DE NEMOURS AND COMPANY- COMPANY SNAPSHOT
  • TABLE 31: E. I. DU PONT DE NEMOURS AND COMPANY - OPERATING SEGMENTS
  • TABLE 32: PROBI AB - COMPANY SNAPSHOT
  • TABLE 33: PROBI AB - OPERATING SEGMENTS
  • TABLE 34: GANEDEN, INC - COMPANY SNAPSHOT
  • TABLE 35: GANEDEN, INC - OPERATING SEGMENTS
  • TABLE 36: PROTEXIN - COMPANY SNAPSHOT
  • TABLE 37: PROTEXIN - OPERATING SEGMENTS
  • TABLE 38: NESTLE S.A. - COMPANY SNAPSHOT
  • TABLE 39: NESTLE S.A.- OPERATING SEGMENTS
  • TABLE 40: CHR. HANSEN HOLDING A/S - COMPANY SNAPSHOT
  • TABLE 41: CHR. HANSEN HOLDING A/S- OPERATING SEGMENTS
  • TABLE 42: LIFEWAY FOODS, INC. - COMPANY SNAPSHOT
  • TABLE 43: LIFEWAY FOODS, INC. - OPERATING SEGMENTS

List of Figures

  • FIG. 1: TOP IMPACTING FACTORS
  • FIG. 2: TOP WINNING STRATEGIES IN PROBIOTICS MARKET
  • FIG. 3: TOP WINNING STRATEGY ANALYSIS (% COMPARISON)
  • FIG. 4: TOP INVESTMENT POCKETS
  • FIG. 5: PORTER'S FIVE FORCES ANALYSIS
  • FIG. 6: VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET
  • FIG. 7: MARKET SHARE ANALYSIS, 2015
  • FIG. 8: WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014 & 2022 (% SHARE)
  • FIG. 9: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF BACTERIA BASED PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 10: WORLD BACTERIA BASED PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 11: WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 12: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF YEAST BASED PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 13: WORLD YEAST BASED PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 14: WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 15: WORLD PROBIOTICS MARKET, BY FUNCTION, 2014 & 2022 (% SHARE)
  • FIG. 16: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF REGULAR FUNCTION PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 17: WORLD REGULAR PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 18: WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 19: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF PREVENTIVE HEALTHCARE FUNCTION MARKET, 2014 & 2022 (%)
  • FIG. 20: WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 21: WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 22: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF THERAPEUTIC FUNCTION IN PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 23: WORLD THERAPEUTIC PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 24: WORLD THERAPEUTIC PROBIOTICS MARKET BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 25: WORLD PROBIOTICS MARKET, BY APPLICATION, 2014 & 2022 (% SHARE)
  • FIG. 26: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FOOD & BEVERAGE SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 27: WORLD FOOD & BEVERAGES PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 28: WORLD FOOD & BEVERAGE PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 29: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF DIETARY SUPPLEMENTS SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 30: WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 31: WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 32: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL FEED SECTOR IN PROBIOTICS, 2014 & 2022 (%)
  • FIG. 33: WORLD ANIMAL FEED PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 34: WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 35: WORLD PROBIOTICS MARKET, BY END USE, 2014 & 2022 (% SHARE)
  • FIG. 36: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF HUMAN PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 37: WORLD HUMAN PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 38: WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 39: COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
  • FIG. 40: WORLD ANIMAL PROBIOTICS MARKET REVENUE, 2014-2022 ($MILLION)
  • FIG. 41: WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014-2022 (%)
  • FIG. 42: WORLD PROBIOTICS MARKET REVENUE, BY GEOGRAPHY (PERCENTAGE COMPARISON), 2015
  • FIG. 43: U.S. PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 44: MEXICO PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 45: CANADA PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 46: UK PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 47: GERMANY PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 48: FRANCE PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 49: ITALY PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 50: REST OF EUROPE PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 51: CHINA PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 52: JAPAN PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 53: INDIA PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 54: REST OF ASIA-PACIFIC PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 55: LATIN AMERICA PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 56: MIDDLE EAST PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 57: AFRICA PROBIOTICS MARKET, 2014-2022 ($MILLION)
  • FIG. 58: YAKULT HONSHA CO., LTD.: NET SALES, 2012-2015 ($MILLION)
  • FIG. 59: YAKULT HONSHA CO., LTD: NET SALES BY BUSINESS SEGMENT (%), 2015
  • FIG. 60: YAKULT HONSHA CO., LTD: NET SALES BY GEOGRAPHY (%), 2015
  • FIG. 61: BIOGAIA AB: NET SALES, 2013-2015 ($MILLION)
  • FIG. 62: NET SALES: BIOGAIA AB, BY BUSINESS SEGMENT (%), 2015
  • FIG. 63: NET SALES: BIOGAIA AB, BY GEOGRAPHY (%), 2015
  • FIG. 64: DANONE: NET SALES, 2013-2015 ($MILLION)
  • FIG. 65: DANONE: NET SALES, BY BUSINESS SEGMENT (%), 2015
  • FIG. 66: DANONE: NET SALES BY GEOGRAPHY (%), 2015
  • FIG. 67: E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, 2013-2015 ($MILLION)
  • FIG. 68: E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, BY SEGMENT (%), 2015
  • FIG. 69: PROBI AB: NET SALES, 2013- 2015 ($MILLION)
  • FIG. 70: PROBI AB: NET SALES BY BUSINESS SEGMENT (%), 2015
  • FIG. 71: PROBI AB: NET SALES BY GEOGRAPHY (%), 2015
  • FIG. 72: NESTLE S.A.: NET SALES, 2013-2015 ($MILLION)
  • FIG. 73: NESTLE S.A.: NET SALES, BY BUSINESS SEGMENT (%), 2015
  • FIG. 74: NESTLE S.A.: NET SALES, BY GEOGRAPHY (%), 2015
  • FIG. 75: CHR. HANSEN HOLDING A/S: NET SALES, 2013- 2015 ($MILLION)
  • FIG. 76: CHR. HANSEN HOLDING A/S: NET SALES BY BUSINESS SEGMENT (%), 2015
  • FIG. 77: CHR. HANSEN HOLDING A/S: NET SALES BY GEOGRAPHY (%), 2015
  • FIG. 78: LIFEWAY FOODS INC.: NET SALES, 2013- 2015 ($MILLION)
  • FIG. 79: LIFEWAY FOODS INC.: NET SALES BY BUSINESS SEGMENT (%), 2015
  • FIG. 80: LIFEWAY FOODS INC.: NET SALES BY GEOGRAPHY (%), 2015
Back to Top